These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 7775958)
1. Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus. Arrazola MP; de Juanes JR; Ramos JT; Aragón AJ; Garcia de Codes A J Med Virol; 1995 Mar; 45(3):339-41. PubMed ID: 7775958 [TBL] [Abstract][Full Text] [Related]
2. Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B. Grosheide PM; del Canho R; Voogd M; Heijtink RA; Schalm SW Vaccine; 1994 Sep; 12(12):1059-63. PubMed ID: 7998413 [TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy, safety and immunogenicity of Hepavax-Gene and Engerix-B, recombinant hepatitis B vaccines, in infants born to HBsAg and HBeAg positive mothers in Vietnam: an assessment at 2 years. Hieu NT; Kim KH; Janowicz Z; Timmermans I Vaccine; 2002 Mar; 20(13-14):1803-8. PubMed ID: 11906768 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of Hepatitis B Vaccine in HIV Exposed Uninfected Infants. Singh DK; Kumar R; Rai R; Maurya M; Bhargava A Indian J Pediatr; 2016 Feb; 83(2):172-4. PubMed ID: 26452493 [TBL] [Abstract][Full Text] [Related]
5. Impaired response to recombinant hepatitis B vaccine in HIV-infected persons. Bruguera M; Cremades M; Salinas R; Costa J; Grau M; Sans J J Clin Gastroenterol; 1992 Jan; 14(1):27-30. PubMed ID: 1532609 [TBL] [Abstract][Full Text] [Related]
6. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination. Boot HJ; Hahné S; Cremer J; Wong A; Boland G; van Loon AM J Viral Hepat; 2010 Dec; 17(12):872-8. PubMed ID: 20051008 [TBL] [Abstract][Full Text] [Related]
7. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers. Thaithumyanon P; Punnahitananda S; Praisuwanna P; Thisyakorn U; Ruxrungtham K J Med Assoc Thai; 2002 Mar; 85(3):277-82. PubMed ID: 12117014 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and efficacy of a recombinant DNA hepatitis B vaccine, GenHevac B Pasteur in high risk neonates, school children and healthy adults. Assateerawatt A; Tanphaichitr VS; Suvatte V; Yodthong S Asian Pac J Allergy Immunol; 1993 Jun; 11(1):85-91. PubMed ID: 8216564 [TBL] [Abstract][Full Text] [Related]
9. Antibody response to hepatitis B vaccine in infants of HIV-positive mothers. Watanaveeradej V; Samakoses R; Kerdpanich A; Aree C; Nitayabhan S; Viputtikul K; Sukwit S Int J Infect Dis; 2002 Sep; 6(3):240-1. PubMed ID: 12718844 [No Abstract] [Full Text] [Related]
10. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects. Ristola MA; Vuola JM; Valle M; von Reyn CF Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038 [TBL] [Abstract][Full Text] [Related]
11. Response to hepatitis B immunization by infants exposed to HIV. Rutstein RM; Rudy B; Codispoti C; Watson B AIDS; 1994 Sep; 8(9):1281-4. PubMed ID: 7802981 [TBL] [Abstract][Full Text] [Related]
12. [Hepatitis B vaccination effectiveness based on anti-HBs antibodies presence in children vertically infected with HIV]. Ołdakowska A; Marczyńska M Przegl Epidemiol; 2010; 64(2):323-8. PubMed ID: 20731246 [TBL] [Abstract][Full Text] [Related]
13. 20 μg hepatitis B vaccination reduced the risk of low responsiveness in infants with HLA-II risk genotype of HBsAg positive mothers. Cao M; Wu Y; Wen S; Pan Y; Wang C; Zhang X; Kong F; Lu Y; Wang C; Niu J; Li J; Jiang J Infect Genet Evol; 2018 Sep; 63():243-248. PubMed ID: 29883771 [TBL] [Abstract][Full Text] [Related]
14. Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda. Seremba E; Van Geertruyden JP; Ssenyonga R; Opio CK; Kaducu JM; Sempa JB; Colebunders R; Ocama P Vaccine; 2017 May; 35(22):2937-2942. PubMed ID: 28434689 [TBL] [Abstract][Full Text] [Related]
15. A 5-year immunization field trial against hepatitis B using a Chinese hamster ovary cell recombinant vaccine in French Polynesian newborns: results at 3 years. Moulia-Pelat JP; Spiegel A; Martin PM; Cardines R; Boutin JP; Roux JF; Excler JL; Saliou P Vaccine; 1994 May; 12(6):499-502. PubMed ID: 8036822 [TBL] [Abstract][Full Text] [Related]
16. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine. Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B vaccination coverage and risk factors associated with incomplete vaccination of children born to hepatitis B surface antigen-positive mothers, Denmark, 2006 to 2010. Kunoee A; Nielsen J; Cowan S Euro Surveill; 2016; 21(7):pii=30136. PubMed ID: 26923681 [TBL] [Abstract][Full Text] [Related]
18. [Hepatitis B immunization in the neonate and the immunocompromised: time to resort to dedicated teams?]. Boillat Blanco N; Manuel O; Vaudaux B Rev Med Suisse; 2012 Apr; 8(338):901-4. PubMed ID: 22611627 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B vaccination in children: the Taiwan experience. Ni YH; Chen DS Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181 [TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen. Lee PI; Lee CY; Huang LM; Chang MH J Pediatr; 1995 May; 126(5 Pt 1):716-21. PubMed ID: 7751994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]